文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

碳离子放疗点扫描技术治疗前列腺癌的初步结果

Preliminary result of carbon-ion radiotherapy using the spot scanning method for prostate cancer.
PubMed 文献 · Radiat Oncol · 2020-05-27

日本神奈川癌症中心回顾性分析2015年12月至2017年12月接受点扫描碳离子放疗的253例前列腺癌患者,处方剂量51.6 Gy(RBE)分12次3周完成。中位随访35.3个月,低、中、高危组3年生化无复发生存率分别为87.5%、88.0%、97.5%(P=0.036),急性和晚期2级泌尿及直肠毒性发生率低,结论认为该技术疗效良好。

要点

  • 点扫描碳离子放疗51.6 Gy(RBE)/12次治疗前列腺癌,中位随访35.3个月。
  • 低、中、高危组3年生化无复发生存率分别为87.5%、88.0%、97.5%。
  • 2级晚期泌尿和直肠毒性分别为6.7%和1.2%,急性2级泌尿毒性4.7%。

核心结论

  • 点扫描碳离子放疗治疗前列腺癌可获得良好的初步临床结局。

研究设计与样本

  • 单中心回顾性分析253例于2015年12月至2017年12月接受点扫描碳离子放疗的前列腺癌患者。

主要发现

  • 中位年龄70岁(范围47-86岁),中位随访35.3个月(范围4.1-52.9个月)。
  • 按D'Amico分类,低危8例、中危88例、高危157例;244例接受雄激素剥夺治疗。
  • 低、中、高危组3年生化无复发生存率分别为87.5%、88.0%、97.5%(P=0.036)。
  • 2级急性泌尿毒性12例(4.7%),未观察到2级急性直肠毒性。
  • 2级晚期泌尿毒性17例(6.7%),2级晚期直肠毒性3例(1.2%);既往经尿道前列腺电切术与晚期2级毒性在单因素分析中显著相关。

关键数值与推荐

  • 照射剂量为51.6 Gy(RBE),分12次,3周内完成。
  • 生化复发采用Phoenix定义,毒性按CTCAE 4.0版评估。

临床怎么用

  • 点扫描碳离子放疗可作为前列腺癌的放疗选择之一,需关注晚期泌尿和直肠毒性。
  • 既往经尿道前列腺电切术可能增加晚期2级毒性风险,治疗决策时应予以考虑。

局限性

  • 本研究为单中心回顾性分析,随访时间有限(中位35.3个月)。
  • 样本以中高危患者为主(低危仅8例),低危组结果解释需谨慎。
  • 晚期直肠毒性的预测因素未检出。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Carbon-ion radiotherapy (CIRT) for prostate cancer was initiated at Kanagawa Cancer Center in 2015. The present study analyzed the preliminary clinical outcomes of CIRT for prostate cancer. METHODS: The clinical outcomes of 253 patients with prostate cancer who were treated with CIRT delivered using the spot scanning method between December 2015 and December 2017 were retrospectively analyzed. The irradiation dose was set at 51.6 Gy (relative biological effectiveness) delivered in 12 fractions over 3 weeks. Biochemical relapse was defined using the Phoenix definition. Toxicities were assessed according to CTCAE version 4.0. RESULTS: The median patient age was 70 (47-86) years. The median follow-up duration was 35.3 (4.1-52.9) months. According to the D'Amico classification system, 8, 88, and 157 patients were classified as having low, intermediate, and high risks, respectively. Androgen deprivation therapy was administered in 244 patients. The biochemical relapse-free rate in the low-, intermediate-, and high-risk groups at 3 years was 87.5, 88.0, and 97.5%, respectively (P = 0.036). Grade 2 acute urinary toxicity was observed in 12 (4.7%) patients. Grade 2 acute rectal toxicity was not observed. Grade 2 late urinary toxicity and grade 2 late rectal toxicity were observed in 17 (6.7%) and 3 patients (1.2%), respectively. Previous transurethral resection of the prostate was significantly associated with late grade 2 toxicity in univariate analysis. The predictive factor for late rectal toxicity was not detected. CONCLUSION: The present study demonstrated that CIRT using the spot scanning method for prostate cancer produces favorable outcomes.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Takakusagi Y, Katoh H, Kano K, et al. Preliminary result of carbon-ion radiotherapy using the spot scanning method for prostate cancer. Radiat Oncol. 2020. PMID: 32460889. doi:10.1186/s13014-020-01575-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。